Newron Pharmaceuticals Announces Prominent Medical Experts to Present at its 2018 R&D Day on October 31 in New York Leading clinicians in the fields of schizophrenia and Rett syndrome, John Kane, MD and Daniel Glaze, MD to present at research and investor update event Milan, Italy and Morristown, NJ, USA - October 15, 2018 - Newron PharmaceuticalsS.p.A. ("Newron") (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system, will host a research and development day featuring leading medical experts presenting on schizophrenia, treatment resistant schizophrenia and Rett syndrome on Wednesday,...
|
